Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 13Endometrial Neoplasms 2Carcinoma, Ductal, Breast 2Peritoneal Neoplasms 1Fallopian Tube Neoplasms 1Cystadenocarcinoma, Serous 1Carcinoma, Lobular 1Breast Neoplasms, Male 1Breast Neoplasm Female 1Breast Carcinoma In Situ 1Breast Cancer Invasive Nos 1Advanced, Persistent, or Recurrent Endometrial Cancer 1

Interventions

Tamoxifen 1Medroxyprogesterone Acetate 1Letrozole 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Advanced, Persistent, or Recurrent Endometrial Cancer × Letrozole × Clear all
NCT02228681 2024-09-19

Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer

GOG Foundation

Phase 2 Completed
74 enrolled 13 charts
Gynecologic

Advanced, Persistent, or Recurrent Endometrial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡